Google
MBAI — CHECK-CAP LTD. (Healthcare >> Diagnostics & Research)
MBAI FAQ
What is MBAI's ROE?
CHECK-CAP LTD. reports a Return on Equity (ROE) of 120.45%.
What is MBAI's dividend yield?
CHECK-CAP LTD. offers a dividend yield of 0.00%.
What is MBAI's Deepscope Quality Score?
Deepscope rates MBAI's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MBAI?
Deepscope's AI Timing Score for MBAI is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MBAI belong to?
CHECK-CAP LTD. is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 1.38
Price
-0.12
(-8.00%)
Day Change
|
|
|---|
MBAI, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.38 |
| PBV / Sector |
2.82 / -23.44
|
| Earning Per Share | 0.66 |
| PE / Sector |
N/A / 37.86
|
| PEG or PE/Growth / Sector |
N/A / 1.41
|
| Average 1M Daily Value |
0.31 M
GREAT
|
| Average 1W Daily Value |
0.12 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:02 |
| Symbol | MBAI |
| Name | CHECK-CAP LTD. |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 7.73 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 9.69 / 32,142.66 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 29 Abba Hushi Avenue, Isfiya, Israel, 3009000
Phone: 972 4 830 3400
Website: https://check-cap.com
Employees: -
Description: Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
